Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Activation of human dendritic...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Activation of human dendritic cells for immunotherapy in ovarian carcinoma
Bibliographic Details
Main Authors:
Brencicova, E
,
Jagger, A
,
Evans, H
,
Laios, A
,
Montalto, S
,
Ahmed, A
,
Raju-Kankipati, S
,
Taams, L
,
Diebold, S
Format:
Conference item
Published:
2012
Holdings
Description
Similar Items
Staff View
Similar Items
Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma
by: Brencicova, E, et al.
Published: (2017)
Dendritic Cell Immunotherapy for Ovarian Cancer: An Overview of Our Achievements
by: Jiřina Bartůňková
Published: (2024-03-01)
Understanding Dendritic Cells and Their Role in Cutaneous Carcinoma and Cancer Immunotherapy
by: Valerie R. Yanofsky, et al.
Published: (2013-01-01)
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
by: João Calmeiro, et al.
Published: (2020-02-01)
A Phase II trial of dendritic cell (DC) immunotherapy for hepatocellular carcinoma
by: Midgley, R, et al.
Published: (2004)